Latest filing published 25 Mar 2024 for EKF Diagnostics Holdings plc, €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -20.9%Entry £0.27 · Close at T+365 £0.21
- -18.4%Entry £0.32 · Close at T+365 £0.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers"): trading record in brief
Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers") appears in our data through filings on EKF Diagnostics Holdings plc shares, published by RNS (LSE). Over a trading history stretching from 9 January 2024 to 22 March 2024, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €65k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 25 March 2024 came the latest disclosure, an open-market purchase for €30k in EKF Diagnostics Holdings plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers")
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲25,780 GBP27RNS100,000 shares@ £0.257846.3% of flowLondon Stock Exchange, AIMXRNS:5118622Canonical exit: 20 Jun 2024 (T+90)
- ▲30,000 GBP27RNS100,000 shares@ £0.3053.7% of flowLondon Stock Exchange, AIMXRNS:5029144Canonical exit: 8 Apr 2024 (T+90)
2 of 2 declarations